Palogic Value Management’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$366K Hold
2,500
0.12% 160
2026
Q1
$368K Buy
2,500
+500
+25% +$81.3K 0.16% 132
2025
Q4
$390K Hold
2,000
0.16% 123
2025
Q3
$562K Hold
2,000
0.23% 107
2025
Q2
$437K Hold
2,000
0.18% 115
2025
Q1
$280K Hold
2,000
0.12% 131
2024
Q4
$333K Hold
2,000
0.13% 134
2024
Q3
$341K Hold
2,000
0.12% 137
2024
Q2
$282K Hold
2,000
0.12% 128
2024
Q1
$251K Hold
2,000
0.11% 138
2023
Q4
$211K Hold
2,000
0.09% 146
2023
Q3
$212K Hold
2,000
0.1% 136
2023
Q2
$238K Buy
+2,000
New +$207K 0.11% 134

Other funds holding ORCL

Palogic Value Management's ORCL Position: Q2 2026 in Review

Palogic Value Management held its Oracle (ORCL) position steady in Q2 2026 at 2,500 shares worth $366K. The position accounts for 0.12% of the portfolio, ranked #160.

Palogic Value Management first reported a position in ORCL in Q2 2023 and has held it in 13 quarters since. The position peaked at $562K in Q3 2025. 3,529 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Palogic Value Management held 2,500 shares of Oracle worth $366K as of Q2 2026.
  • Palogic Value Management left its Oracle share count unchanged in Q2 2026.
  • Oracle made up 0.12% of Palogic Value Management's portfolio in Q2 2026, its #160 holding.
  • Palogic Value Management first reported a position in Oracle in Q2 2023 and has held it in 13 quarters since.
  • Palogic Value Management's Oracle position peaked at $562K in Q3 2025.
  • 3,529 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Palogic Value Management's 13F filing for Q2 2026, filed 14 Aug 2026.